Krystal Biotech, Inc. 4KB.F Stock
Krystal Biotech, Inc. Price Chart
Krystal Biotech, Inc. 4KB.F Financial and Trading Overview
| Krystal Biotech, Inc. stock price | 167.45 EUR |
| Previous Close | 118 EUR |
| Open | 112 EUR |
| Bid | 112 EUR x 0 |
| Ask | 115 EUR x 0 |
| Day's Range | 112 - 112 EUR |
| 52 Week Range | 48 - 119 EUR |
| Volume | 70 EUR |
| Avg. Volume | 2 EUR |
| Market Cap | 2.94B EUR |
| Beta (5Y Monthly) | 0.833802 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.37 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 98.43 EUR |
4KB.F Valuation Measures
| Enterprise Value | 2.7B EUR |
| Trailing P/E | N/A |
| Forward P/E | -30.68493 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.90157 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -21.134 |
Trading Information
Krystal Biotech, Inc. Stock Price History
| Beta (5Y Monthly) | 0.833802 |
| 52-Week Change | 145.83% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 119 EUR |
| 52 Week Low | 48 EUR |
| 50-Day Moving Average | 86.37 EUR |
| 200-Day Moving Average | 75.28 EUR |
4KB.F Share Statistics
| Avg. Volume (3 month) | 2 EUR |
| Avg. Daily Volume (10-Days) | 9 EUR |
| Shares Outstanding | 25.8M |
| Float | 18.94M |
| Short Ratio | N/A |
| % Held by Insiders | 15.02% |
| % Held by Institutions | 83.10% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -14.32% |
| Return on Equity (ttm) | -26.068% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -127884000 EUR |
| Net Income Avi to Common (ttm) | -135307008 EUR |
| Diluted EPS (ttm) | -4.9 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 350.39M EUR |
| Total Cash Per Share (mrq) | 13.58 EUR |
| Total Debt (mrq) | 8.76M EUR |
| Total Debt/Equity (mrq) | 1.79 EUR |
| Current Ratio (mrq) | 10.133 |
| Book Value Per Share (mrq) | 18.978 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -111232000 EUR |
| Levered Free Cash Flow (ttm) | -109634128 EUR |
Profile of Krystal Biotech, Inc.
| Country | Germany |
| State | PA |
| City | Pittsburgh |
| Address | 2100 Wharton Street |
| ZIP | 15203 |
| Phone | 412 586 5830 |
| Website | https://www.krystalbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 210 |
Krystal Biotech, Inc., a biotechnology company, develops and commercializes genetic medicines for patients with rare diseases in the United States. It develops beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa; KB105 for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for netherton syndrome; and KB407 for Cystic Fibrosis. The company also develops KB408 for Alpha-1 antitrypsin deficiency; and KB301 for aesthetic skin conditions. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
Q&A For Krystal Biotech, Inc. Stock
What is a current 4KB.F stock price?
Krystal Biotech, Inc. 4KB.F stock price today per share is 167.45 EUR.
How to purchase Krystal Biotech, Inc. stock?
You can buy 4KB.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Krystal Biotech, Inc.?
The stock symbol or ticker of Krystal Biotech, Inc. is 4KB.F.
Which industry does the Krystal Biotech, Inc. company belong to?
The Krystal Biotech, Inc. industry is Biotechnology.
How many shares does Krystal Biotech, Inc. have in circulation?
The max supply of Krystal Biotech, Inc. shares is 28.51M.
What is Krystal Biotech, Inc. Price to Earnings Ratio (PE Ratio)?
Krystal Biotech, Inc. PE Ratio is 452.56757000 now.
What was Krystal Biotech, Inc. earnings per share over the trailing 12 months (TTM)?
Krystal Biotech, Inc. EPS is 0.37 EUR over the trailing 12 months.
Which sector does the Krystal Biotech, Inc. company belong to?
The Krystal Biotech, Inc. sector is Healthcare.